Yujiro S. Hata

Stories

IDEAYA Biosciences raises $324 million as lead cancer drug nears FDA filing

As of June 2026: Leading the company toward its first FDA filing

IDEAYA Biosciences closed a $323.6 million stock sale on June 10, 2026. The cash lands as the company prepares to file its first drug with the U.S. Food and Drug Administration (FDA).

Updated Jun 10